Quick answer

The DEA's July 2026 action targets concentrated 7-hydroxymitragynine (7-OH) and three lab-made analogues — not the kratom plant itself. Products that stay outside the proposed threshold, most notably natural kratom leaf and powder with only trace 7-OH, are explicitly excluded and remain federally legal. Categories defined by high, isolated, or synthesized 7-OH are the ones affected. Federal legality is only half the picture, so always verify your current state law before you buy.

If you follow the 7-OH space, you have probably seen a wave of "what's still legal?" questions since the DEA moved to schedule concentrated 7-OH in July 2026. This post is a neutral map of the landscape: what the proposed rule actually covers, which product categories fall outside that line, and how to confirm any given product's status where you live. We make no health, effect, or medical claims here — this is strictly about legal status, botanical facts, and lab testing.

What exactly is the 2026 rule targeting?

On July 1, 2026, the DEA filed two Notices of Intent to temporarily place four substances into Schedule I under the emergency-scheduling mechanism at 21 U.S.C. 811(h). Those notices publish in the Federal Register on July 6, 2026 (dockets DEA-1570 for 7-OH; DEA-1644 for the analogues). The four substances are:

  • 7-hydroxymitragynine (7-OH) in concentrated form
  • mitragynine pseudoindoxyl
  • MGM-15 (dihydro-7-hydroxymitragynine)
  • MGM-16 (9-fluoro-7-hydroxymitragynine)

Important for timing: a temporary order like this cannot take effect until at least 30 days after the July 6 publication — so on or after roughly August 5, 2026. The initial term runs two years (extendable to three). Permanent scheduling would require a separate rulemaking that has not started. A related HHS Request for Information (docket HHS-OASH-2026-0232) is accepting public comments through July 31, 2026. As of this writing, no lawsuit challenging the scheduling has been filed; industry groups have said they are reviewing options.

Where is the legal line drawn?

The threshold is the single most useful thing to understand, because it defines what counts as "in" versus "out." As written, the intended coverage is:

Category Covered by the proposed rule?
Mitragyna speciosa plant material over 0.050% 7-OH by dry weight Yes
Any synthetic or processed article (extract, concentrate, edible, beverage, pressed pill/tablet) over 0.050% 7-OH by weight (w/w, w/v, v/v) Yes
Any article containing more than 1.00 mg of 7-OH per package/article Yes
Natural kratom leaf/powder with low trace 7-OH (under the threshold) No — explicitly excluded, remains federally legal

In plain terms: the rule is drawn around concentration. A product is affected when 7-OH is present above 0.050% by weight, or when a single package carries more than 1.00 mg of 7-OH. Natural kratom leaf, which contains only trace amounts of 7-OH, sits below that line and was specifically carved out.

What are the 7-OH alternatives that stay legal?

"Alternative" here means a product category that falls outside the DEA threshold — nothing more. We are comparing on legal status and botanical facts, not on how anything performs or feels. The categories that are unaffected by the proposed federal rule include:

  • Natural kratom leaf and powder. The most direct example of an excluded category. Whole-leaf and plain milled powder from Mitragyna speciosa carry only trace 7-OH and remain federally legal under the proposed rule. Explore plain leaf options on our powder collection.
  • Traditional leaf-based formats generally. Capsules or pressed tablets made from natural leaf powder — not from isolated or added 7-OH — stay outside the threshold as long as they remain under 0.050% and under 1.00 mg of 7-OH per package. Verify this with a current lab report before assuming it, since tablets and edibles are exactly the formats the rule scrutinizes. See what's on offer in our tablets collection.
  • Products with no Mitragyna speciosa content at all. Anything that is not derived from the kratom plant is, by definition, outside these particular dockets. That is a botanical statement, not a comparison of anything else.

The common thread is simple: legality here follows the numbers on the lab report, not the product name on the label. A "kratom" tablet is not automatically safe from scheduling if its 7-OH content crosses the threshold, and a product marketed as an alternative is not automatically legal either. The Certificate of Analysis settles it.

How do I verify a product is actually under the threshold?

Because the entire rule turns on measured 7-OH content, third-party lab testing is the only reliable way to confirm where a product sits. Look for:

  • A published Certificate of Analysis (COA) from an ISO/IEC 17025-accredited lab.
  • A stated 7-OH figure you can compare directly to the 0.050% and 1.00 mg-per-package limits.
  • Batch or lot matching between the COA and the product you're holding.

We publish our testing on our lab results page so you can read the numbers yourself rather than take a label's word for it. If a seller can't or won't show you a current, batch-matched COA, treat the legal status as unverified.

Does federal legality mean it's legal where I live?

No — and this is the step most people skip. Federal exclusion does not override state law, and several states regulate or ban kratom (including 7-OH) independently. As a snapshot to illustrate the range, and not as legal advice:

  • Full kratom bans that include 7-OH: Alabama, Arkansas, Indiana, Vermont, Wisconsin (longstanding); Louisiana (2025); Connecticut (2026); Tennessee and Kansas (effective July 1, 2026).
  • Targeted 7-OH or concentration rules: Florida (AG emergency rule, 2025, concentrated 7-OH); Colorado (SB25-072, 2025); Ohio (Board of Pharmacy rule, effective May 2026, 7-OH plus analogues); Mississippi (2025, potency cap, 21+, behind-the-counter).

State statutes change quickly, so always confirm the current law for your state before purchasing. What is federally excluded today may still be restricted where you live.

A note for retailers and wholesale buyers

If you sell rather than buy, there's an added layer: payment processing. Card-network rules (for example, Mastercard BRAM) and individual processors have restricted 7-OH transactions, and processors actively monitor merchant sites and can terminate accounts. That is a real, near-term business risk independent of the DEA timeline. Retailers and distributors sourcing compliant, lab-tested product can find wholesale information at 7ohblack.com.

Frequently asked questions

Is natural kratom leaf banned under the 2026 rule?

No. Natural kratom leaf and powder with only trace 7-OH fall below the proposed 0.050% threshold and were explicitly excluded. They remain federally legal under the rule as written, though state law may still apply.

Is 7-OH illegal right now?

Not as of July 4, 2026. The DEA filed Notices of Intent on July 1, 2026, publishing July 6. A temporary Schedule I order cannot take effect until at least 30 days after publication — on or after roughly August 5, 2026.

What makes a product "over the threshold"?

A product is covered if 7-OH exceeds 0.050% by weight (w/w, w/v, or v/v) or if a single package/article contains more than 1.00 mg of 7-OH. Plant material over 0.050% by dry weight is also covered.

How can I tell if a specific product qualifies as an alternative?

Check the Certificate of Analysis. A COA from an ISO/IEC 17025-accredited lab shows the measured 7-OH content, which you can compare directly to the 0.050% and 1.00 mg-per-package limits.

If it's federally excluded, can I buy it anywhere in the U.S.?

Not necessarily. Several states ban or restrict kratom and 7-OH regardless of federal status. Always verify your current state statute before purchasing.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For adults 21 and older, where legal.

Shop Lab-Tested 7-OH

Precision-dosed tablets and high-purity powder — every batch third-party tested with a published COA.

7-OH Tablets · 7-OH Powder · Lab Results

Keep Reading